Dixon Troy 4

What Happened Troy Dixon, MD and Co‑Head of Global Markets at Tradeweb Markets (TW), sold 2,584 shares on March 20, 2026 at $125.75 per share for proceeds of $324,938. The sale was reported on a Form 4 filed March 24, 2026. This was a sale (not a purchase); the transaction was executed under a pre‑established trading plan.

Key Details

• Transaction date and price: March 20, 2026 — 2,584 shares sold at $125.75 each (total $324,938).
• Method: Reported as an open‑market/private sale (code S).
• 10b5‑1 plan: Footnote confirms the sale was effected under a Rule 10b5‑1 plan adopted December 15, 2025.
• Shares/ownership: The filing notes that the reported beneficial ownership figure includes 21,013 unvested RSUs (vesting in equal installments March 15, 2027 and March 15, 2028) and 10,850 unvested RSUs (vesting in equal installments March 15, 2027, 2028 and 2029) — a total of 31,863 unvested RSUs. The full post‑sale total of shares beneficially owned was not specified in the excerpt provided.
• Filing timeliness: Form 4 was filed on March 24 for a March 20 trade; this appears to meet the standard two‑business‑day reporting deadline.

Context Sales made under a 10b5‑1 plan are executed according to a previously established schedule and are commonly viewed as routine rather than an immediate signal of the insider’s view on the company. For retail investors, purchases by insiders typically carry more weight as a direct bullish signal; disclosed sales like this are informative about timing and quantity but not necessarily about management sentiment.